Exhibit 107

Calculation of Filing Fee Tables

S-1

(Form Type)

ASPIRE BIOPHARMA HOLDINGS, INC.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

		Security Type				Security Class Title		Fee Calculation or Carry Forward Rule				Amount Registered				Proposed Maximum Offering Price Per Unit				Maximum Aggregate Offering Price (1)				Fee Rate				Amount of Registration Fee (3)				Carry Forward Form Type				Carry Forward File Number				Carry Forward Initial Effective Date				Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward
Newly Registered Securities
Fees to be Paid			Equity			Common Stock, $0.001 par value per share			Rule 457(c)				159,090,906				1.31	(4)		$	208,409,086	(4)		$	0.00013810			$	28,781.29
Fees to be Paid			Equity			Series A Convertible Preferred Stock (2)			Rule 457(c)				—				—				—				—				—
Fees to be Paid			Equity			Common Stock, issuable upon the conversion of the Series A Convertible Preferred Stock			Rule 457(c)				—				—				—				—				—
Fees Previously Paid			—			—			—				—				—				—				—				—
Carry Forward Securities
Carry Forward Securities			—			—			—				—				—				—				—				—				—				—				—				—
Total Offering Amounts																				$	208,409,086			$	0.00013810			$	28,781.29
Total Fees Previously Paid																													—
Total Fee Offset																													—
Net Fee Due																												$	28,781.29

(1)	Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended (the “Securities Act”). Represents only the additional number of shares being registered. This does not include the securities that the Registrant previously registered on the Registration Statement on Form S-1.
(2)	No separate fee is required pursuant to Rule 457(g) under the Securities Act.
(3)	The registration fee is calculated in accordance with Rule 457(a) under the Securities Act of 1933, as amended, or the Securities Act, based on the proposed maximum aggregate offering price.
(4)	The Price per share used to obtain the maximum offering amount of such Common Stock for the purposes of calculating the registration fee was the average of the high and low trading prices of the Company’s Common Stock reported by Nasdaq on February 13, 2026, which was $1.31.

N/A